Cargando…

Metabolic effects of reduced growth hormone action in fatty liver disease

BACKGROUND: Adult growth hormone (GH) deficiency is associated with fatty liver disease and shows several features of the metabolic syndrome. Vice versa obesity is characterized as a state of low GH function. Here, we aimed to define the role of hepatic GH signaling and its metabolic consequences in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rufinatscha, Kerstin, Ress, Claudia, Folie, Sabrina, Haas, Simone, Salzmann, Karin, Moser, Patrizia, Dobner, Jochen, Weiss, Guenter, Iruzubieta, Paula, Arias-Loste, María Teresa, Crespo, Javier, Tilg, Herbert, Kaser, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208861/ https://www.ncbi.nlm.nih.gov/pubmed/30206761 http://dx.doi.org/10.1007/s12072-018-9893-7

Ejemplares similares

Cardioprotective effects of short-term empagliflozin treatment in db/db mice
por: Radlinger, Bernhard, et al.
Publicado: (2020)

Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
por: Radlinger, Bernhard, et al.
Publicado: (2022)

The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?
por: Iruzubieta, Paula, et al.
Publicado: (2015)

Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
por: Santos-Laso, Alvaro, et al.
Publicado: (2021)

Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
por: Alonso-Peña, Marta, et al.
Publicado: (2023)

Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease
por: Del Barrio, María, et al.
Publicado: (2023)

Intraepithelial lymphocytes subsets in different forms of celiac disease
por: Sánchez-Castañon, M., et al.
Publicado: (2016)

Deficiency of GABARAP but Not Its Paralogs Causes Enhanced EGF-Induced EGFR Degradation
por: Dobner, Jochen, et al.
Publicado: (2020)

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
por: Odriozola, Aitor, et al.
Publicado: (2023)

LOXL2—A New Target in Antifibrogenic Therapy?
por: Puente, Angela, et al.
Publicado: (2019)

Irisin, a Link among Fatty Liver Disease, Physical Inactivity and Insulin Resistance
por: Arias-Loste, María Teresa, et al.
Publicado: (2014)

The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease
por: Arias-Loste, María Teresa, et al.
Publicado: (2015)

Successful Direct Acting Antiviral Therapy in Chronic Hepatitis C Normalizes IFNγ and IL2 Production in T Cells Together with TLR8 Expression and Functionality in Peripheral Blood Mononuclear Cells
por: Arias-Loste, María Teresa, et al.
Publicado: (2021)

Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy
por: Puente, Angela, et al.
Publicado: (2019)

Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease
por: Arias-Loste, María Teresa, et al.
Publicado: (2016)

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2019)

Epidemiology of intrafamilial inflammatory bowel disease throughout Europe
por: Arias-Loste, Maria Teresa, et al.
Publicado: (2012)

Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity
por: Lamadrid, Patricia, et al.
Publicado: (2021)

Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors
por: Wieser, Verena, et al.
Publicado: (2017)

Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It
por: Puente, Angela, et al.
Publicado: (2019)

High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort
por: Llop, Elba, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
por: Grander, Christoph, et al.
Publicado: (2023)

Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding
por: Fortea, José Ignacio, et al.
Publicado: (2018)

Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)
por: Lavín-Alconero, Lucía, et al.
Publicado: (2021)

Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
por: Adolph, Timon E., et al.
Publicado: (2017)

A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
por: Iruzubieta, Paula, et al.
Publicado: (2020)

Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
por: Tilg, Herbert, et al.
Publicado: (2021)

SARS-CoV-2 detection by self-testing: A method to improve surveillance programmes
por: Iruzubieta, Paula, et al.
Publicado: (2021)

SARS-CoV-2 detection by self-testing: A method to improve surveillance programmes
por: Iruzubieta, Paula, et al.
Publicado: (2021)

Acute bolus obstruction following surgical treatment of paraesophageal herniation of the greater omentum
por: Rassam, S, et al.
Publicado: (2021)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

MAFLD: what 2 years of the redefinition of fatty liver disease has taught us
por: Grabherr, Felix, et al.
Publicado: (2022)

Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways
por: Nairz, Manfred, et al.
Publicado: (2011)

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
por: Calleja, José L., et al.
Publicado: (2022)

Biochemical assessment of metabolic associated fatty liver disease
por: Guerra-Ruiz, Armando R., et al.
Publicado: (2021)

COVID-19 and the gastrointestinal tract: more than meets the eye
por: Ng, Siew C, et al.
Publicado: (2020)

Andere spezifische Diabetesformen und exokrine Pankreasinsuffizienz (Update 2023)
por: Kaser, Susanne, et al.
Publicado: (2023)

SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination
por: Crespo, Javier, et al.
Publicado: (2021)

Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world
por: Crespo, Javier, et al.
Publicado: (2021)

Dietary Factors: Major Regulators of the Gut's Microbiota
por: Moschen, Alexander R., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ieubq8ldhaf8sgvvih5n1qe2gb